KREBSBIOMARKER

European patent · EP3593139 · In force

Register entry

Publication number
EP3593139
Application number
EP18710027
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 7, 2018
Published
Jan 15, 2020
Granted
Aug 27, 2025
Protection ends at the latest
Mar 6, 2038
Next annual fee due
Mar 31, 2027
IPC classes
G01N 33/574 (2006.01)
G01N 33/66 (2006.01)
Priority
GB 201703640 07.03.2017
GB 201703641 07.03.2017
PCT application
PCT/EP2018/055670 07.03.2018
PCT publication
WO2018/162596 13.09.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 8, 2026

    Change

    Published in Swissreg on 08.07.2026

  2. Apr 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.03.2026 → 31.03.2027

    Published in Swissreg on 01.04.2026

  3. Oct 6, 2025

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 06.10.2025

  4. Aug 27, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 27.08.2025

Parties

Holder

ELYPTA AB

Scheeles väg 3, 171 65 Solna, SE

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

GATTO, Francesco

36100 Vicenza, IT

NIELSEN, Jens

41128 Gothenburg, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.